Bellerophon Therapeutics Inc buy marge
Start price
12.04.17
/
50%
€16.37
Target price
23.01.20
€67.65
Performance (%)
-68.11%
End price
23.01.20
€5.22
Summary
This prediction ended on 23.01.20 with a price of €5.22. The BUY prediction by marge for Bellerophon Therapeutics Inc performed very badly with a performance of -68.11%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bellerophon Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | -1.283% | 4.209% | 7.084% | 64.252% |
| iShares Nasdaq 100 | -3.338% | -1.744% | 26.177% | 84.969% |
| iShares Nikkei 225® | -4.286% | -1.621% | 44.320% | 79.253% |
| iShares S&P 500 | -2.311% | -0.096% | 20.823% | 68.079% |
Comments by marge for this prediction
In the thread Bellerophon Therapeutics Inc diskutieren
marge stimmt der Buy-Einschätzung von datca zu
marge stimmt am 12.04.2017 der Buy-Einschätzung von datca mit dem Kursziel 5$ zu.
Überschrift: Bellerophon, erfolgreich tätig im Markt der Pulmonary Arterial Hypertension